Anodyne Nanotech

company

About

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.

Details

Last Funding Type
Seed
Last Funding Money Raised
$4.20M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Anodyne Nanotech, Inc.

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery.

The company was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$6.20M
Anodyne Nanotech has raised a total of $6.20M in funding over 2 rounds. Their latest funding was raised on May 3, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 3, 2021 Seed $4.20M 3 Detail
Aug 7, 2020 Seed $2M 2 Velocity.Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
4
Anodyne Nanotech is funded by 4 investors. Relativity Healthcare Partners and Big Pi are the most recent investors.
Investor Name Lead Investor Funding Round
Relativity Healthcare Partners Seed
Big Pi Seed
Velocity.Partners Seed
Bantam Group Seed

Employee Profiles

Number of Employee Profiles
4
Anodyne Nanotech has 4 current employee profiles, including Board member Michael S. Singer
Board member
Executive
Executive